TABLE 1.
Characteristics of anionic coexpression partners and cationic AMPs
| Peptide | Mass (Da) | pI | Amino acid sequence (N to C terminus)a |
|---|---|---|---|
| Coexpression partners | |||
| mIF | 17,575 | 4.70 | CYCQDPYVKEAENLKKYFNAGHSDVADNGTLFLGILKNWKEESDEDIMQSQIVSFYFKLFKNFKDDQSIQKSMETIKEEMNVKFFNSNKKKRDDFEKLTNYSVTDLNVQRKAIHELIQVMAELSDAAKTGEDEDSQMLFRGRRASQEEVE |
| mIFc1 | 10,881 | 4.35 | CYCQDPYVKEAENLKKYFNAGHSDVADNGTLFLGILKNWKEESDEDIMQSQIVSFYFKLFKNFKDDQSIQKSMETIKEEMNVKFFNSNEEVE |
| mIFc2 | 7,371 | 4.12 | CYCQDPYVKEAENLKKYFNAGHSDVADNGTLFLGILKNWKEESDEDIMQSQIVSFYFKLEEVE |
| mIFc3 | 5,541 | 4.14 | CYCQDPYVKEAENLKKYFNAGHSDVADNGTLFLGILKNWKEESDEEVE |
| AMPs | |||
| BIIb | 2,560 | 13.27 | RAGLQFPVGRLLRRLLRRLLR |
| Parasin I | 2,000 | 12.84 | KGRGKQGGKVRAKAKTRSS |
| Pexiganan | 2,478 | 11.71 | GIGKFLKKAKKFGKAFVKILKK |
a
Substitution of amino acids is indicated by underlining. The substitutions are as follows: R45E, K46D, K131E, R132D, K133E, and R134D. The region containing the SD sequence, EEVE, is indicated in boldface.